Moderna begins testing omicron-specific COVID-19 vaccine in adults

Moderna has begun testing an omicron-specific COVID-19 booster in healthy adults.

Article_Normal, Biotechnology

1/27/2022 2:57:00 AM

It’s not clear whether global health authorities will order a change to the vaccine recipe in the wake of the hugely contagious omicron variant, since the original vaccines still offer good protection.

Moderna has begun testing an omicron-specific COVID-19 booster in healthy adults.

The company announced Wednesday that the first participant had received a dose. Earlier this week, competitor Pfizer PFE, +0.89% began a similar study of its own reformulated shots.It’s not clear whether global health authorities will order a change to the vaccine recipe in the wake of the hugely contagious omicron variant. The original vaccines still offer good protection against death and severe illness. Studies in the U.S. and elsewhere show a booster dose strengthens that protection and improves the chances of avoiding even a milder infection.

Read more: MarketWatch »

Schiaparelli Fall 2022 Couture Collection

Schiaparelli Fall 2022 Couture collection, runway looks, beauty, models, and reviews. Read more >>

Covid-19 news: Strain on health services led to extra non-covid deathsToday’s covid-19 news: · 4000 excess non-covid 19 deaths occurred in England during first year of pandemic · Acute phase of pandemic could end in 2022 with improved vaccination rates, says WHO · Israel recommends fourth vaccine dose for all adults The most deadly pandemic in US, Abortion 2017 =862,000 US goes crazy with covid deaths =650,000 You know who else spread fake news? Adolf Hitler “tell a big enough lie and tell it frequently enough, it will be believed.”

Red wine could reduce chances of COVID-19 infection, U.K. study suggestsA recent study out of the U.K. suggested consuming up to two glasses of red wine a week could lower a person’s chance of getting infected with COVID-19. Two glasses of wine improve a person’s chances on getting laid as well 🤷🏻‍♂️😂 I’ve got a study I pulled out of my arse that shows snorting a fat line of crank everyday will “lower the chance” of getting COVID… Why are YOU (Fox29) spreading this COVID misinformation? I thought that was supposed to be a bad thing? 🤔🤬

Highly Touted COVID-19 Antiviral Treatments In Short SupplyPhysicians hope production of the pills will ramp up, but also acknowledge that could take several months.

Illinois schools could see fewer student quarantines from COVID-19 close contactsIllinois students who are exposed to COVID-19 but already had a confirmed case of the virus in the past three months will no longer be excluded from the classroom. Stupid

COVID-19 vaccines could temporarily impact length of menstrual cycles, study saysThe women who received a vaccine saw an increase in cycle length of nearly one day for each dose, according to the study.

Covid-19 news: Infections in England remain at ‘extremely high’ levelToday’s covid-19 news: · Infections in England remain at very high levels as cases rise in children · 98 per cent of UK adults have antibodies to virus that causes covid-19 · Two studies identify markers that may predict long covid

CAMBRIDGE, Mass. (AP) — The company announced Wednesday that the first participant had received a dose. Earlier this week, competitor Pfizer PFE, +0.89% began a similar study of its own reformulated shots. It’s not clear whether global health authorities will order a change to the vaccine recipe in the wake of the hugely contagious omicron variant. The original vaccines still offer good protection against death and severe illness. Studies in the U.S. and elsewhere show a booster dose strengthens that protection and improves the chances of avoiding even a milder infection. See also: Walmart, Costco and other big box stores in Canada begin enforcing vaccine mandates, and some shoppers aren’t buying it Moderna MRNA, +1.59% pointed to a small study published in the New England Journal of Medicine on Wednesday that showed antibodies able to target omicron persisted for six months after a booster dose, although the levels were dropping. Moderna’s new study will enroll about 600 people who already have received either two doses of the company’s original shots or two plus a booster dose. All the volunteers will receive a dose of the experimental omicron-matched version.